Investing

RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

by admin
written by admin

Radiopharm Theranostics (RAD:AU) has announced RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

Download the PDF here.

This post appeared first on investingnews.com

0 comment
0
FacebookTwitterPinterestEmail

Related Posts

Crypto Market Update: SEC Pauses Bitwise ETF Conversion...

5 Best-performing Canadian Oil and Gas Stocks of...

White House Unveils 90 Point AI Strategy

Joe Cavatoni: Gold’s Key Driver Now, Catalyst for...

Walker Lane Resources Ltd. Announces Closing of Private...

JZR Gold Announces Closing Of Non-Brokered Private Placement...

Heritage Announces LIFE Offering and Provides Corporate and...

10 Biggest Cannabis Stocks in the US and...

Sarama Resources Completes Mt Venn Gold Project Acquisition

Altech Batteries LtdCerenergy Battery Project Funding Progressing Well

Leave a Comment

Save my name, email, and website in this browser for the next time I comment.